Shu, Xing-Sheng <br/><br/>
The epigenetic modifier PBRM1 restricts the basal activity of the innate immune system by repressing retinoic acid-inducible gene-I-like receptor signalling and is a potential prognostic biomarker for colon cancer.  [electronic resource] 

 -  The Journal of pathology  01 2018 
 - 36-48 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1096-9896 
<br/><br/><label>Standard No.: </label>10.1002/path.4986  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers--metabolism<br/>Colonic Neoplasms--diagnosis<br/>DEAD Box Protein 58--genetics<br/>DNA-Binding Proteins<br/>Epigenomics<br/>Female<br/>Humans<br/>Immunity, Innate<br/>Inflammatory Bowel Diseases--complications<br/>Interferon-Induced Helicase, IFIH1--genetics<br/>Male<br/>Nuclear Proteins--genetics<br/>Prognosis<br/>RNA, Small Interfering<br/>Receptors, Immunologic<br/>Sequence Analysis, RNA<br/>Signal Transduction<br/>Transcription Factors--genetics<br/>Tretinoin--metabolism<br/>Tripartite Motif Proteins--genetics<br/>Ubiquitin-Protein Ligases--genetics<br/>Ubiquitination